Sana Biotechnology's total assets for Q3 2024 were $559.39M, a decrease of -9.58% from the previous quarter. SANA total liabilities were $266.91M for the fiscal quarter, a -4.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.